A decade of aggressive acquisitions propels Stryker into diverse and innovative MedTech markets.
Stryker’s focus on mergers and acquisitions (M&A) has defined its growth strategy under CEO Kevin Lobo. Since 2012, the company has completed more than 60 acquisitions, balancing organic innovation and external opportunities.
Strategic Acquisitions: From Robotics to Virtual Nursing
Stryker’s notable deals include:
- Mako Surgical (2013): Acquired for $1.7 billion to strengthen orthopedic robotics.
- Physio-Control (2016): Defibrillator business transformed into a consistent double-digit growth segment.
- Vocera Communications (2022): $3.1 billion purchase addressing nursing shortages with alarm fatigue solutions.
- Care.ai (2024): Introduced virtual nursing to reduce workloads and enhance patient care.
- Vertos Medical (2024): Expanded minimally invasive solutions for spinal stenosis and back pain.
Offensive, Not Defensive M&A
“We fight off the front foot,” said Andy Pierce, President of MedSurg and Neurotechnology. Stryker’s offensive M&A approach targets high-growth adjacencies and technologies that improve patient care, like neuromodulation and soft-tissue robotics.
Stryker’s diversified portfolio positions it as a leader in innovation, continually addressing the evolving needs of healthcare professionals and patients.
Follow MEDWIRE.AI for updates on MedTech strategies and innovations.
